We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LI icon
726
Li Auto
LI
$12.6B
$304K 0.02%
12,000
-21,086
-64% -$546K
SBSW icon
727
Sibanye-Stillwater
SBSW
$7.55B
$304K 0.02%
+27,041
New +$236K
CCCXW
728
DELISTED
Churchill Capital Corp X Warrants
CCCXW
$302K 0.02%
+85,000
New +$125K
CAEP
729
DELISTED
Cantor Equity Partners III
CAEP
$301K 0.02%
+29,177
New +$305K
NTCT icon
730
NETSCOUT
NTCT
$2.81B
$301K 0.02%
+11,648
New +$276K
MTG icon
731
MGIC Investment
MTG
$6.21B
$300K 0.02%
+10,563
New +$288K
MOS icon
732
The Mosaic Company
MOS
$7.46B
$298K 0.02%
+8,602
New +$296K
ZTS icon
733
Zoetis
ZTS
$30.9B
$298K 0.02%
2,034
+570
+39% +$86.2K
UWMC icon
734
UWM Holdings
UWMC
$2.26B
$297K 0.02%
+48,741
New +$256K
SHY icon
735
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$296K 0.02%
+3,570
New +$295K
UPB
736
Upstream Bio Inc
UPB
$405M
$296K 0.02%
+15,735
New +$244K
ATEC icon
737
Alphatec Holdings
ATEC
$1.47B
$296K 0.02%
20,338
+5,666
+39% +$78.9K
NDSN icon
738
Nordson
NDSN
$17.2B
$295K 0.02%
+1,301
New +$287K
PJT icon
739
PJT Partners
PJT
$4.33B
$294K 0.02%
+1,657
New +$298K
AMD icon
740
Advanced Micro Devices
AMD
$767B
$294K 0.02%
1,819
-6,599
-78% -$1.06M
AMP icon
741
Ameriprise Financial
AMP
$49.2B
$294K 0.02%
+598
New +$306K
NUE icon
742
Nucor
NUE
$62.5B
$293K 0.02%
2,166
-14,233
-87% -$2.01M
GOLD
743
Gold.com Inc
GOLD
$1.26B
$292K 0.02%
11,295
+226
+2% +$5.35K
PM icon
744
Philip Morris
PM
$290B
$291K 0.02%
1,796
+33
+2% +$5.55K
PRU icon
745
Prudential Financial
PRU
$42.1B
$291K 0.02%
+2,808
New +$296K
VLTO icon
746
Veralto
VLTO
$23.7B
$290K 0.02%
2,721
+499
+22% +$52.6K
CTRI icon
747
Centuri Holdings
CTRI
$2.4B
$290K 0.02%
+13,684
New +$290K
TTEC icon
748
TTEC Holdings
TTEC
$113M
$289K 0.02%
86,019
+7,403
+9% +$30.4K
BCPC
749
Balchem Corp
BCPC
$5.65B
$289K 0.02%
+1,923
New +$303K
CGEM icon
750
Cullinan Oncology
CGEM
$1.18B
$289K 0.02%
48,652
+32,500
+201% +$238K

Similar funds

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.